NCT03739489

Brief Summary

Repetitive transcranial magnetic stimulation is a non-invasive neuromodulation technique used to treat different neuropsychiatric disorders, such as, depression, neuropathic pain, fibromyalgia and obsessive-compulsive disorder. It is known that the heart rate variability is altered in these conditions. Therefore the focus of this research is to show the influence of rTMS on the Heart Rate Variability.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2018

Completed
4 days until next milestone

Study Start

First participant enrolled

April 1, 2018

Completed
8 months until next milestone

First Posted

Study publicly available on registry

November 13, 2018

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

November 13, 2018

Status Verified

November 1, 2018

Enrollment Period

8 months

First QC Date

March 28, 2018

Last Update Submit

November 9, 2018

Conditions

Keywords

healthy subjectsrepetitive transcranial magnetic stimulationheart rate variability

Outcome Measures

Primary Outcomes (1)

  • Heart rate variability changes

    Changes in heart rate variability measured by Polar V800

    Three times during the entire study. Following the scheme, Until 1 hour before each session, 15 minutes along the each session and until 1 hour after the end of session

Secondary Outcomes (2)

  • Conditioned Pain Modulation

    48 hours before the first session of stimulation

  • Volume in

    1 week before the first session of stimulation

Study Arms (3)

rTMS-PSI

ACTIVE COMPARATOR

Participants allocated in this arm will receive active repetitive transcranial magnetic stimulation over the posterior superior insula right.

Procedure: Repetitive transcranial magnetic stimulation

rTMS-M1

ACTIVE COMPARATOR

Participants allocated in this arm will receive active repetitive transcranial magnetic stimulation over the right primary motor cortex.

Procedure: Repetitive transcranial magnetic stimulation

rTMS-F3

ACTIVE COMPARATOR

Participants allocated in this arm will receive active repetitive transcranial magnetic stimulation over the left pre frontal dorsolateral cortex.

Procedure: Repetitive transcranial magnetic stimulation

Interventions

Repetitive transcranial magnetic stimulation was a technique able to modulate the brain circuit restoring the function.

rTMS-F3rTMS-M1rTMS-PSI

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Agreed participate the protocol
  • Signing the consent form
  • Do not present any cardiac problems or disease

You may not qualify if:

  • Trauma of Skull, epilepsy don't treated,
  • Use of medications decrease the seizure threshold
  • Patients in use of drugs, how cocaine and alcohol
  • Neurosurgical clips, pacemakers, increased intracranial pressure (risk of sequelae after seizure)
  • Pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC/FMUSP)

São Paulo, São Paulo, 05403900, Brazil

Location

MeSH Terms

Interventions

Transcranial Magnetic Stimulation

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The participant will be received three different sessions of rtms, with wash out 30 days between sessions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor, Clinical Research

Study Record Dates

First Submitted

March 28, 2018

First Posted

November 13, 2018

Study Start

April 1, 2018

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

November 13, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations